Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Digestion|December 29, 2016
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pyloriMasahiro Tsujimae, Hiroshi Yamashita, Hiroki Hashimura, et al.
The British Journal of Nutrition|January 14, 2009
Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: the JACC StudyJunko Nagura, Hiroyasu Iso, Yoshiyuki Watanabe, et al.
Surgical Endoscopy|June 20, 2019
Intra-abdominal pressure during endoscopic full-thickness resection comparing manual and automatic control insufflation: a block-randomized porcine studyShunsuke Kamba, Masakuni Kobayashi, Akio Koizumi, et al.
Diabetes Research and Clinical Practice|November 23, 2017
Whole-exome sequencing in a Japanese family with highly aggregated diabetes identifies a candidate susceptibility mutation in ADAMTSL3Byambatseren Jambaljav, Daisuke Tanaka, Kazuaki Nagashima, et al.
Pulmonary Circulation|May 3, 2018
Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in miceHatasu Kobayashi, Risako Kabata, Hideyuki Kinoshita, et al.
Environmental Health and Preventive Medicine|June 29, 2011
Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional studyShanika Nanayakkara, S T M L D Senevirathna, Upul Karunaratne, et al.
Environmental Health and Preventive Medicine|July 2, 2009
Reconstruction of human exposure to heavy metals using synchrotron radiation microbeams in prehistoric and modern humansAkio Koizumi, Miki Azechi, Koyo Shirasawa, et al.
Journal of the American Heart Association|July 2, 2015
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In VivoHatasu Kobayashi, Yoshiko Matsuda, Toshiaki Hitomi, et al.
The Lancet. Neurology|May 23, 2022
Moyamoya disease: diagnosis and interventionsMasafumi Ihara, Yumi Yamamoto, Yorito Hattori, et al.
Stroke and Vascular Neurology|April 23, 2025
Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya diseaseYohei Mineharu, Takahiko Kamata, Mei Tomoto, et al.
Pageof 23